Show Nav →
Please include the following statement when referencing the CPTAC Assay Portal
We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Overview Data source: UniProt

Official Gene Symbol Other Aliases
FSCN1 FAN1, HSN, SNL
Sequence Length (AA) Molecular Weight (Da)
493 54530
Protein Name
Fascin
Sources
UniProt
PhosphoSitePlus ®
GeneCards
Human Protein Atlas

Protein Sequence hover to view complete sequence

10 20 30 40 50
MTANGTAEAV QIQFGLINCG NKYLTAEAFG FKVNASASSL KKKQIWTLEQ
60 70 80 90 100
PPDEAGSAAV CLRSHLGRYL AADKDGNVTC EREVPGPDCR FLIVAHDDGR
110 120 130 140 150
WSLQSEAHRR YFGGTEDRLS CFAQTVSPAE KWSVHIAMHP QVNIYSVTRK
160 170 180 190 200
RYAHLSARPA DEIAVDRDVP WGVDSLITLA FQDQRYSVQT ADHRFLRHDG
210 220 230 240 250
RLVARPEPAT GYTLEFRSGK VAFRDCEGRY LAPSGPSGTL KAGKATKVGK
260 270 280 290 300
DELFALEQSC AQVVLQAANE RNVSTRQGMD LSANQDEETD QETFQLEIDR
310 320 330 340 350
DTKKCAFRTH TGKYWTLTAT GGVQSTASSK NASCYFDIEW RDRRITLRAS
360 370 380 390 400
NGKFVTSKKN GQLAASVETA GDSELFLMKL INRPIIVFRG EHGFIGCRKV
410 420 430 440 450
TGTLDANRSS YDVFQLEFND GAYNIKDSTG KYWTVGSDSA VTSSGDTPVD
460 470 480 490 493
FFFEFCDYNK VAIKVGGRYL KGDHAGVLKA SAETVDPASL WEY

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node
to view detailed assay information below
All other points link out to UniProt



Phosphorylation Acetylation Ubiquitylation Other

loading

Loader

Assay Details for CPTAC-1403 Collapse assay details

Data source: Panorama

Official Gene Symbol
FSCN1
Peptide Sequence
FLIVAHDDGR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
91
Peptide End
100
CPTAC ID
CPTAC-1403
Peptide Molecular Mass
1,141.5880
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
depleted digested plasma
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma. Abbatiello SE, Schilling B, Mani DR, Zimmerman LJ, Hall SC, MacLean B, Albertolle M, Allen S, Burgess M, Cusack MP, Gosh M, Hedrick V, Held JM, Inerowicz HD, Jackson A, Keshishian H, Kinsinger CR, Lyssand J, Makowski L, Mesri M, Rodriguez H, Rudnick P, Sadowski P, Sedransk N, Shaddox K, Skates SJ, Kuhn E, Smith D, Whiteaker JR, Whitwell C, Zhang S, Borchers CH, Fisher SJ, Gibson BW, Liebler DC, MacCoss MJ, Neubert TA, Paulovich AG, Regnier FE, Tempst P, Carr SA. Mol Cell Proteomics. 2015 Sep;14(9):2357-74. doi: 10.1074/mcp.M114.047050. Epub 2015 Feb 18. PMID: 25693799


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva TSQ
Internal Standard
heavy stable isotope peptide (delta 8-10)
Peptide Standard Purity
>95%
Peptide Standard Label Type
15N
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y8 (2+) 3.3 1 1.5 3.8 5.6 2.9 5 5.7 3.3 15 15 15
y7 (2+) 3 2.5 3.2 5.5 6.2 4.4 6.3 6.7 5.4 15 15 15
y5 (2+) 4.5 2.4 2.7 5.1 6.1 3.7 6.8 6.6 4.6 15 15 15
sum 2.1 1 1.6 2.4 5.6 3.1 3.2 5.7 3.5 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-1406 Collapse assay details

Data source: Panorama

Official Gene Symbol
FSCN1
Peptide Modified Sequence
LSC[+57.0]FAQTVSPAEK
Modification Type
Carbamidomethyl Cysteine
Protein - Site of Modification
121
Peptide - Site of Modification
3
Peptide Start
119
Peptide End
131
CPTAC ID
CPTAC-1406
Peptide Molecular Mass
1,436.6970
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
depleted digested plasma
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma. Abbatiello SE, Schilling B, Mani DR, Zimmerman LJ, Hall SC, MacLean B, Albertolle M, Allen S, Burgess M, Cusack MP, Gosh M, Hedrick V, Held JM, Inerowicz HD, Jackson A, Keshishian H, Kinsinger CR, Lyssand J, Makowski L, Mesri M, Rodriguez H, Rudnick P, Sadowski P, Sedransk N, Shaddox K, Skates SJ, Kuhn E, Smith D, Whiteaker JR, Whitwell C, Zhang S, Borchers CH, Fisher SJ, Gibson BW, Liebler DC, MacCoss MJ, Neubert TA, Paulovich AG, Regnier FE, Tempst P, Carr SA. Mol Cell Proteomics. 2015 Sep;14(9):2357-74. doi: 10.1074/mcp.M114.047050. Epub 2015 Feb 18. PMID: 25693799


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva TSQ
Internal Standard
heavy stable isotope peptide (delta 8-10)
Peptide Standard Purity
>95%
Peptide Standard Label Type
15N
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y9 (1+) 4.5 2.4 1.5 5.9 5.9 4 7.4 6.4 4.3 15 15 15
y7 (1+) 3.3 2.3 2.3 11.3 6.2 3.7 11.8 6.6 4.4 15 15 15
y5 (1+) 2.4 2.9 1.7 5.5 6.5 2.8 6 7.1 3.3 15 15 15
sum 1.9 2.4 1.1 6.6 6.2 2.5 6.9 6.6 2.7 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-1405 Collapse assay details

Data source: Panorama

Official Gene Symbol
FSCN1
Peptide Sequence
VTGTLDANR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
400
Peptide End
408
CPTAC ID
CPTAC-1405
Peptide Molecular Mass
945.4880
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
depleted digested plasma
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma. Abbatiello SE, Schilling B, Mani DR, Zimmerman LJ, Hall SC, MacLean B, Albertolle M, Allen S, Burgess M, Cusack MP, Gosh M, Hedrick V, Held JM, Inerowicz HD, Jackson A, Keshishian H, Kinsinger CR, Lyssand J, Makowski L, Mesri M, Rodriguez H, Rudnick P, Sadowski P, Sedransk N, Shaddox K, Skates SJ, Kuhn E, Smith D, Whiteaker JR, Whitwell C, Zhang S, Borchers CH, Fisher SJ, Gibson BW, Liebler DC, MacCoss MJ, Neubert TA, Paulovich AG, Regnier FE, Tempst P, Carr SA. Mol Cell Proteomics. 2015 Sep;14(9):2357-74. doi: 10.1074/mcp.M114.047050. Epub 2015 Feb 18. PMID: 25693799


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva TSQ
Internal Standard
heavy stable isotope peptide (delta 8-10)
Peptide Standard Purity
>95%
Peptide Standard Label Type
15N
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y7 (1+) 3.4 3.5 2.2 5 5.4 4.3 6 6.4 4.8 15 15 15
y5 (1+) 5 3.6 2.6 6.9 6.6 4.2 8.5 7.5 4.9 15 15 15
y4 (1+) 5.1 1.4 2.4 6.2 5.7 3.4 8 5.9 4.2 15 15 15
sum 3.3 2.6 2 4.7 5.6 3.8 5.7 6.2 4.3 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-1404 Collapse assay details

Data source: Panorama

Official Gene Symbol
FSCN1
Peptide Sequence
YLAPSGPSGTLK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
230
Peptide End
241
CPTAC ID
CPTAC-1404
Peptide Molecular Mass
1,189.6343
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
depleted digested plasma
Submitting Laboratory
Broad Institute
Submitting Lab PI
Steven A. Carr

Publication

View Details (opens in a new window)

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma. Abbatiello SE, Schilling B, Mani DR, Zimmerman LJ, Hall SC, MacLean B, Albertolle M, Allen S, Burgess M, Cusack MP, Gosh M, Hedrick V, Held JM, Inerowicz HD, Jackson A, Keshishian H, Kinsinger CR, Lyssand J, Makowski L, Mesri M, Rodriguez H, Rudnick P, Sadowski P, Sedransk N, Shaddox K, Skates SJ, Kuhn E, Smith D, Whiteaker JR, Whitwell C, Zhang S, Borchers CH, Fisher SJ, Gibson BW, Liebler DC, MacCoss MJ, Neubert TA, Paulovich AG, Regnier FE, Tempst P, Carr SA. Mol Cell Proteomics. 2015 Sep;14(9):2357-74. doi: 10.1074/mcp.M114.047050. Epub 2015 Feb 18. PMID: 25693799


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
Quantiva TSQ
Internal Standard
heavy stable isotope peptide (delta 8-10)
Peptide Standard Purity
>95%
Peptide Standard Label Type
15N
LC
Easy NanoLC1000
Column Packing
Reprosil C18, 1.9um, 200A
Column Dimensions
0.075 x 150 mm
Flow Rate
200 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y10 (1+) 4 1.5 1.4 5.6 6.8 2.5 6.9 7 2.9 15 15 15
y9 (1+) 3.1 1.6 1.3 4.7 5.2 3 5.6 5.4 3.3 15 15 15
y8 (1+) 3.9 2.8 2.1 4.9 7.2 2.9 6.3 7.7 3.6 15 15 15
sum 2.3 1.5 1.2 4.3 5.8 2.7 4.9 6 3 15 15 15


Additional Resources and Comments


Assay Details for CPTAC-373 Collapse assay details

Data source: Panorama

Official Gene Symbol
FSCN1
Peptide Sequence
LVARPEPATGYTLEFR
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
202
Peptide End
217
CPTAC ID
CPTAC-373
Peptide Molecular Mass
1,818.9628
Species
Homo sapiens (Human)
Assay Type
Direct MRM
Matrix
cell line lysate pool
Submitting Laboratory
Broad Institute and FHCRC
Submitting Lab PI
Steve Carr

Publication

View Details (opens in a new window)

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Kennedy JJ, Abbatiello SE, Kim K, Yan P, Whiteaker JR, Lin C, Kim JS, Zhang Y, Wang X, Ivey RG, Zhao L, Min H, Lee Y, Yu MH, Yang EG, Lee C, Wang P, Rodriguez H, Kim Y, Carr SA, Paulovich AG. Nat Methods. 2014 Feb;11(2):149-55. doi: 10.1038/nmeth.2763. Epub 2013 Dec 8. PMID: 24317253


Response curves acquired at Broad Institute. Repeatability data acquired at Fred Hutchinson Cancer Research Center.


Response curves acquired at Broad Institute. Repeatability data acquired at Fred Hutchinson Cancer Research Center.


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
5500 QTRAP (ABSCIEX)
Internal Standard
peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
13C,15N
LC
nanoLC-Ultra 2D, cHiPLC-nanoflex (Eksigent)
Column Packing
ChromXP C18-CL, 3 um, 120A
Column Dimensions
150 x 0.075 mm
Flow Rate
500 nL / min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y7 (1+) 8.8 10.2 7 9.5 10.2 7.3 12.9 14.4 10.1 15 25 15
y5 (1+) 7.2 6.2 4.4 12.9 7.3 6 14.8 9.6 7.4 15 25 15
y14 (2+) 5.2 10.8 12.7 20.2 30.4 18.5 20.9 32.3 22.4 15 25 15
sum 4.4 7.5 7.2 12.5 13.8 9.6 13.3 15.7 12 15 25 15


Additional Resources and Comments


Assay Details for CPTAC-709 Collapse assay details

Data source: Panorama

Official Gene Symbol
FSCN1
Peptide Sequence
YLAPSGPSGTLK
Modification Type
unmodified
Protein - Site of Modification
N/A
Peptide - Site of Modification
N/A
Peptide Start
230
Peptide End
241
CPTAC ID
CPTAC-709
Peptide Molecular Mass
1,189.6343
Species
Homo sapiens (Human)
Assay Type
Enrichment MRM
Enrichment Method
N/A
Matrix
plasma
Submitting Laboratory
Fred Hutchinson Cancer Research Center
Submitting Lab PI
Amanda Paulovich

Publication

View Details (opens in a new window)

Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA. Schoenherr RM, Saul RG, Whiteaker JR, Yan P, Whiteley GR, Paulovich AG. Mol Cell Proteomics. 2015 Feb;14(2):382-98. doi: 10.1074/mcp.O114.043133. Epub 2014 Dec 15. PMID: 25512614


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument
5500 Qtrap
Internal Standard
synthetic peptide
Peptide Standard Purity
>95%
Peptide Standard Label Type
15N
LC
Eksigent NanoLC 2D
Column Packing
ReproSil-Pur C18-AQ 3 um
Column Dimensions
100 mm x 75 um ID
Flow Rate
300 nL/min

Assay Multiplexing Expand assay panel

Broad Institute-Plasma-based Candidate Cancer Biomarkers

CPTAC-1372:
ALDOC.
ALQASALNAWR
CPTAC-1373:
ALDOC.
AEVNGLAAQGK
CPTAC-1374:
ALDOC.
ELSDIALR
CPTAC-1375:
ALDOC.
TPSALAILENANVLAR
CPTAC-1376:
ALDOC.
QVLFSADDR
CPTAC-1377:
ANXA1.
ALYEAGER
CPTAC-1378:
ANXA1.
GTDVNVFNTILTTR
CPTAC-1379:
ANXA1.
AAYLQETGKPLDETLK
CPTAC-1380:
ANXA1.
TPAQFDADELR
CPTAC-1381:
ANXA4.
VLVSLSAGGR
CPTAC-1382:
ANXA4.
GLGTDEDAIISVLAYR
CPTAC-1383:
ANXA4.
DEGNYLDDALVR
CPTAC-1384:
ANXA4.
GAGTDEGC[+57.0]LIEILASR
CPTAC-1385:
ANXA7.
LYQAGEGR
CPTAC-1386:
ANXA7.
SEIDLVQIK
CPTAC-1387:
ANXA7.
GAGTDDSTLVR
CPTAC-1388:
ANXA7.
EFSGYVESGLK
CPTAC-1389:
ANXA7.
GFGTDEQAIVDVVANR
CPTAC-1390:
CALR.
QIDNPDYK
CPTAC-1391:
CALR.
FYALSASFEPFSNK
CPTAC-1392:
CALR.
EQFLDGDGWTSR
CPTAC-1393:
CLIC1.
LHIVQVVC[+57.0]K
CPTAC-1394:
CLIC1.
YLSNAYAR
CPTAC-1395:
CLIC1.
IEEFLEAVLC[+57.0]PPR
CPTAC-1396:
CLIC1.
GVTFNVTTVDTK
CPTAC-1397:
CLIC1.
GFTIPEAFR
CPTAC-1398:
EZR.
IQVWHAEHR
CPTAC-1399:
EZR.
EDEVEEWQHR
CPTAC-1400:
EZR.
SGYLSSER
CPTAC-1401:
EZR.
IALLEEAR
CPTAC-1402:
EZR.
SQEQLAAELAEYTAK
CPTAC-1403:
FSCN1.
FLIVAHDDGR
CPTAC-1404:
FSCN1.
YLAPSGPSGTLK
CPTAC-1405:
FSCN1.
VTGTLDANR
CPTAC-1406:
FSCN1.
LSC[+57.0]FAQTVSPAEK
CPTAC-1407:
FTL.
LGGPEAGLGEYLFER
CPTAC-1408:
FTL.
KPAEDEWGK
CPTAC-1409:
FEN1.
SIEEIVR
CPTAC-1410:
FEN1.
QLQQAQAAGAEQEVEK
CPTAC-1411:
FEN1.
LIADVAPSAIR
CPTAC-1412:
GSTP1.
FQDGDLTLYQSNTILR
CPTAC-1413:
GSTP1.
EEVVTVETWQEGSLK
CPTAC-1414:
GSTP1.
PPYTVVYFPVR
CPTAC-1415:
GSTP1.
ASC[+57.0]LYGQLPK
CPTAC-1416:
GLO1.
FSLYFLAYEDK
CPTAC-1417:
GLO1.
SLDFYTR
CPTAC-1418:
GLO1.
IAWALSR
CPTAC-1419:
GLO1.
GFGHIGIAVPDVYSAC[+57.0]K
CPTAC-1420:
GLO1.
FEELGVK
CPTAC-1421:
GRB2.
FNSLNELVDYHR
CPTAC-1422:
GRB2.
FGNDVQHFK
CPTAC-1423:
GRB2.
NYVTPVNR
CPTAC-1424:
GRB2.
ATADDELSFK
CPTAC-1425:
GRB2.
ESESAPGDFSLSVK
CPTAC-1426:
HSPB1.
LFDQAFGLPR
CPTAC-1427:
HSPB1.
AQLGGPEAAK
CPTAC-1428:
HSPB1.
VSLDVNHFAPDELTVK
CPTAC-1429:
HSPB1.
DGVVEITGK
CPTAC-1430:
HSPB1.
QLSSGVSEIR
CPTAC-1431:
IL18.
EDELGDR
CPTAC-1432:
IL18.
SDIIFFQR
CPTAC-1433:
IL18.
TIFIISMYK
CPTAC-1434:
IL18.
ISTLSC[+57.0]ENK
CPTAC-1435:
IL18.
GMAVTISVK
CPTAC-1436:
LGALS1.
DGGAWGTEQR
CPTAC-1437:
LGALS1.
DSNNLC[+57.0]LHFNPR
CPTAC-1438:
LGALS1.
FNAHGDANTIVC[+57.0]NSK
CPTAC-1439:
LGALS1.
SFVLNLGK
CPTAC-1440:
LGALS1.
LPDGYEFK
CPTAC-1441:
PDLIM1.
C[+57.0]GTGIVGVFVK
CPTAC-1442:
PDLIM1.
VAASIGNAQK
CPTAC-1443:
PDLIM1.
VWSPLVTEEGK
CPTAC-1444:
PDLIM1.
DFEQPLAISR
CPTAC-1445:
PRDX2.
GLFIIDGK
CPTAC-1446:
PRDX2.
TDEGIAYR
CPTAC-1447:
PRDX2.
ATAVVDGAFK
CPTAC-1448:
PRDX4.
DYGVYLEDSGHTLR
CPTAC-1449:
PRDX4.
LVQAFQYTDK
CPTAC-1450:
PRDX4.
IPLLSDLTHQISK
CPTAC-1451:
PRDX4.
QITLNDLPVGR
CPTAC-1452:
S100A1.
ELLQTELSGFLDAQK
CPTAC-1453:
S100A2.
ELPSFVGEK
CPTAC-1454:
S100B.
AMVALIDVFHQYSGR
CPTAC-1455:
S100B.
ELINNELSHFLEEIK
CPTAC-1456:
RAD23B.
EQVIAALR
CPTAC-1457:
RAD23B.
IDIDPEETVK
CPTAC-1458:
RAD23B.
ILNDDTALK
CPTAC-1459:
SNCG.
EGVVGAVEK
CPTAC-1460:
SNCG.
ENVVQSVTSVAEK
CPTAC-1461:
SNCG.
TVEEAENIAVTSGVVR
CPTAC-1462:
TPM1.
LVIIESDLER
CPTAC-1463:
TPM1.
SIDDLEDELYAQK
CPTAC-1464:
TPM1.
QLEDELVSLQK
CPTAC-1465:
UBE2C.
YLQETYSK
CPTAC-1466:
UBE2C.
LSLEFPSGYPYNAPTVK
CPTAC-1467:
UBE2C.
DPAATSVAAAR
CPTAC-1468:
UBE2C.
GISAFPESDNLFK
CPTAC-1469:
UBE2I.
DDYPSSPPK
CPTAC-1470:
UBE2I.
DWRPAITIK
CPTAC-1471:
UBE2I.
DHPFGFVAVPTK

Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader

Repeatability

Data source: Panorama

  Average intra-assay CV
(within day CV)
Average inter-assay CV
(between day CV)
Total CV
equation
n=
Fragment ion / Transition Low Med High Low Med High Low Med High Low Med High
y8 (1+) 16.4 3.4 1.9 24.5 5.6 4.1 29.5 6.6 4.5 15 15 15
y9 (1+) 15 3 1.7 20.4 6.1 3.2 25.3 6.8 3.6 15 15 15
y10 (1+) 14.5 6 1.8 24.3 6.4 4.5 28.3 8.8 4.8 15 15 15
sum 12.4 3.2 1.1 18.5 5.4 3.5 22.3 6.3 3.7 15 15 15


Additional Resources and Comments